Positron emission tomography (PET) combined with magnetic resonance imaging (MRI) is a hybrid technology that brings together molecular sensitivity & specificity, morphologic and functional imaging to enable simultaneous, complimentary small animal imaging that does not alter the physiological state. This complimentary, simultaneous imaging opens new areas to explore across various fields including neuroscience, cancer, metabolic disease, and molecular probe development.
PET/MR combines the fields of nuclear medicine, molecular imaging and radiology to provide simultaneous, complementary small animal imaging that does not alter physiological parameters. In this webinar, preclinical molecular imaging experts Peter Caravan and Michael Heidenreich will discuss the synergies of this hybrid technology and the new avenues of exploration it opens up across areas ranging from neuroscience, cancer, and metabolic disease through to dual molecular probe development.
The implementation of state-of-the-art hybrid PET/MR technologies will be discussed with a focus on the PET Insert Si198 for mice and rats, applications using the Bruker BioSpec 47/40 PET/MR, and the introduction of the new PET Insert Si103 for mice and rat head applications using small bore Bruker MRI scanner
This webinar took place on June 25th, 2020
The benefits of combining the modalities for complementary imaging will be discussed, including a doubling of the information obtained and the unchanged physiological state once the two devices are used together rather than individually. Novel applications enabled by the hybrid technology in the field of preclinical imaging will be described and the first results of the new PET Insert Si 103 will be introduced.
This webinar will interest researchers in the fields of nuclear medicine, molecular imaging and radiology and would also appeal to anyone working in the field of biomedical imaging.
Dr. Peter Caravan
Harvard University
Dr. Michael Heidenreich
Bruker Vice President Nuclear Molecular Imaging